Skip to main content
DBD
NYSE Technology

Millstreet Capital Management Reduces Stake in Diebold Nixdorf by $42.5 Million

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$88.602
Mkt Cap
$3.09B
52W Low
$39.96
52W High
$88.91
Market data snapshot near publication time

Summary

Millstreet Capital Management, a 10% owner, reported additional open market sales of 112,305 shares for approximately $9.56 million, bringing their total reported sales in this amendment to $42.52 million.


Key Events

  • Significant Share Sales

    Millstreet Capital Management, along with its managing members, reported selling a total of 512,234 common shares in open market transactions between April 8 and April 16, 2026.

  • Total Transaction Value

    The aggregate value of these sales amounted to approximately $42.52 million.

  • Updated Ownership Stake

    Following these transactions, the reporting persons now collectively hold 4,704,438 shares, representing 13.38% of Diebold Nixdorf's common stock.

  • Sales Near 52-Week High

    The sales occurred at prices ranging from $82.41 to $85.43 per share, while the company's stock is trading near its 52-week high of $88.91.


Analysis

This Schedule 13D/A updates Millstreet Capital Management's ownership stake in Diebold Nixdorf, disclosing further open market sales. While a Form 4 on April 10, 2026, covered sales up to $32.9 million, this amendment adds sales of 112,305 shares for approximately $9.56 million on April 15 and 16, 2026. The total reported transactions in this filing, amounting to approximately $42.52 million, represent a significant reduction in their position, occurring while the stock trades near its 52-week high. As a 10% owner, their selling activity suggests a rebalancing of their portfolio or a decision to lock in profits, rather than a fundamental shift in the company's outlook. Investors should note the continued reduction in stake by a major institutional holder.

At the time of this filing, DBD was trading at $88.60 on NYSE in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $39.96 to $88.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBD - Latest Insights

DBD
Apr 30, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $83.81 info
Change: +$1.31 (+2%) info
Market Cap: $2.902B info
DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $88.60
Real-time Price: $83.81 info
Change: -$4.79 (-5%) info
Market Cap: $2.902B info
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $84.78
Real-time Price: $83.81 info
Change: -$0.970 (-1%) info
Market Cap: $2.902B info
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $75.59
Real-time Price: $83.81 info
Change: +$8.22 (+11%) info
Market Cap: $2.902B info
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $72.36
Real-time Price: $83.81 info
Change: +$11.45 (+16%) info
Market Cap: $2.902B info
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $68.61
Real-time Price: $83.81 info
Change: +$15.20 (+22%) info
Market Cap: $2.902B info
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $68.61
Real-time Price: $83.81 info
Change: +$15.20 (+22%) info
Market Cap: $2.902B info
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7
Price at Filing: $69.91
Real-time Price: $83.81 info
Change: +$13.90 (+20%) info
Market Cap: $2.902B info